India Q2 Preview: Glenmark, Cipla Emerge Stronger

Remdesivir Sales Could Taper Slightly in Q3

 
• By Vibha Ravi
  
Forecast
Analysts Forecast Q2 Gains For Indian Firms Though Growth Will Be Uneven • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip